Sign inJoin waitlistJoin the waitlist

David Michelson

Medical Director, Muscular Dystrophy Clinic · Loma Linda University Health Education Consortium

Credentials: · ·

History

Muscular Dystrophy Clinic · Loma Linda University Health Education Consortium
Present
Complex Epilepsy Team Center · Loma Linda University Health Education Consortium
Present
Loma Linda University Health Education Consortium
Present

LOMA LINDA UNIVERSITY HEALTH
2004–2007
Child Neurology
Loma Linda University Health Education Consortium
2001–2004
Pediatrics
Kaiser Permanente Medical Center
1998–2001
David Geffen Sch of Med at UCLA
1994–1998

Research

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
New England Journal of Medicine · 2018 · Last of 15 authors · 507 citations
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study
PEDIATRICS · 2001 · First of 8 authors · Corresponding · 478 citations
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study
American Journal of Psychiatry · 2002 · First of 15 authors · Corresponding · 437 citations

TS
Thomas Spencer
16 papers
Frederick Reimherr
14 papers
Lenard Adler
14 papers
KC
Kathryn Connor
12 papers
Stephen Ashwal
12 papers
JB
Joseph Biederman
11 papers
PG
Philip Gold
11 papers
JA
Jay Amsterdam
10 papers
JN
Jeffrey Newcorn
9 papers
Chris Kratochvil
8 papers
AA
Albert Allen
7 papers
Andrew Krystal
7 papers

Clinical trials

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Site PI · Recruiting
Catalyst Pharmaceuticals, Inc.
2024–2032